Trader: Low Volume ...
Consumer Goods: Consumer Non-Durables
Carlisle Companies Inc. (CSL: NYSE)
$48.69 -1.12 | -2.25%
06/04/12 - 04:00 PM ET
Growth Rates
| GROWTH RATES |
|---|
| REVENUE (Trailing 12 Quarters) |
| EARNINGS PER SHARE (Trailing 12 Quarters) |
| DIVIDENDS (Trailing 12 Quarters) |
Portfolios with CSL
- Portfolio NameUser Type
- ContributorTop-Rated Industrial Conglo...
- ContributorDividend Stocks for the Wee...
- UserTop Dividend Increasers for...
- Usermarkinhi Portfolio 1
- UserCGIC
- Userazhester Portfolio 1
- UserRich's Gems
- UserBarron's Interview With Nic...
- Userc bgvm 1848
- UserStreet Legal
Latest CSL Headlines from TheStreet
- Carlisle Companies Stock To Go Ex-dividend Monday (CSL) 05.18.12 | 10:05 am
- Ex-Dividend Stocks: Valero Energy, Mattel 05.18.12 | 05:05 am
- Carlisle Companies Reaches New 52-Week High (CSL) 05.01.12 | 02:05 pm
- Analysts' Actions: AAPL, AXE, PNRA, DD 04.25.12 | 08:04 am
- Carlisle Companies' CEO Discusses Q1 2012 Results - Earnings Call Transcript 04.24.12 | 02:04 pm
- Carlisle Companies Stock Gaps Up On Today's Open (CSL) 04.24.12 | 10:04 am
- Carlisle Companies Reaches New 52-Week High (CSL) 04.02.12 | 11:04 am
- Carlisle Companies Stock Hits New 52-Week High (CSL) 03.13.12 | 05:03 pm
- Carlisle Companies Reaches New 52-Week High (CSL) 02.21.12 | 11:02 am
- Carlisle Companies Stock To Go Ex-dividend Tomorrow (CSL) 02.14.12 | 08:02 am
Press Releases for CSL
- CSL Behring Announces FDA Filing Of Biologics License Application For 4-Factor PCC For Urgent Reversal Of Vitamin K Antagonist Anticoagulant Therapy - PR Newswire 05.29.12 | 02:05 pm
- Carlisle Companies To Present At KeyBanc Capital Markets Conference May 30 - Business Wire 05.29.12 | 09:05 am
- Carlisle Construction Materials To Add PVC Manufacturing - PR Newswire 05.22.12 | 03:05 pm
- Carlisle Companies To Present At Oppenheimer’s Industrials Conference May 16 - Business Wire 05.15.12 | 09:05 am
- CSL Behring Initiates Study Of Subcutaneous Administration Of C1-esterase Inhibitor In Patients With Hereditary Angioedema - PR Newswire 05.03.12 | 03:05 pm
- Carlisle Companies Declares Regular Quarterly Dividend - Business Wire 05.02.12 | 10:05 am
- Carlisle Companies To Announce 1st Quarter 2012 Earnings On April 24 - Business Wire 04.02.12 | 09:04 am
- CSL Behring Commences Phase I Study With RVIIa-FP, A Novel Therapy To Treat People With Hemophilia A And Hemophilia B Who Have Inhibitors - PR Newswire 03.30.12 | 02:03 pm
- First Patient Enrolled In CSL Behring PATH Trial To Evaluate Immune Globulin Subcutaneous (Human) 20% Liquid, Hizentra®, In The Treatment Of CIDP - PR Newswire 03.26.12 | 10:03 am
- Carlisle Companies To Present At Sidoti’s Institutional Investor Forum On March 20 - Business Wire 03.19.12 | 09:03 am
Partner Headlines for CSL
- Zacks #1 Rank Additions for Wednesday - Tale of the Tape - Zacks 01.25.12 | 09:01 am
- Zacks #1 Rank Additions for Thursday - Tale of the Tape - Zacks 01.19.12 | 09:01 am
- Zacks #1 Rank Additions for Thursday - Tale of the Tape - Zacks 01.12.12 | 09:01 am
- 3 Dividend Plays From The Rubber And Plastics Industry - Seeking Alpha 11.06.11 | 08:11 am
- 3M Company Earnings Preview: Analysts Expect Higher EPS, Revenue - Benzinga 10.20.11 | 01:10 pm
- Carlisle Companies - Value - Zacks 06.08.11 | 01:06 am
- Zacks #1 Rank Additions for Thursday - Tale of the Tape - Zacks 05.05.11 | 09:05 am
- UPDATE 1-Carlisle net drops on charges, raw material costs - Reuters 02.07.11 | 07:02 am
- Carlisle Companies - Value - Zacks 01.14.11 | 01:01 am
- Zacks #1 Rank Additions for Wednesday - Tale of the Tape - Zacks 01.05.11 | 09:01 am
